Psychosomatic Medicine
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS

Published online before print February 2, 2009, 10.1097/PSY.0b013e3181907c1b
This Article
Right arrow Figures Only
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrowRequest Permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Howren, M. B.
Right arrow Articles by Suls, J.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Howren, M. B.
Right arrow Articles by Suls, J.
Related Collections
Right arrow Immunology
Right arrow Depression
Psychosomatic Medicine 71:171-186 (2009)
© 2009 American Psychosomatic Society


REVIEW ARTICLES

Associations of Depression With C-Reactive Protein, IL-1, and IL-6: A Meta-Analysis

M. Bryant Howren, MA, Donald M. Lamkin, MA and Jerry Suls, PhD

From the Department of Psychology, The University of Iowa, Iowa City, Iowa.

Address correspondence and reprint requests to Jerry Suls, Department of Psychology, The University of Iowa, 11 Seashore Hall East, Iowa City, IA 52242. E-mail: jerry-suls{at}uiowa.edu

Objective: To assess the magnitude and direction of associations of depression with C-reactive protein (CRP), interleukin (IL)-1, and IL-6 in community and clinical samples.

Methods: Systematic review of articles published between January 1967 and January 2008 in the PubMed and PsycINFO electronic databases was performed. Effect sizes were calculated as stat d and meta-analyzed, using random-effects models.

Results: Each inflammatory marker was positively associated with depression; CRP, d = 0.15 (95% CI = 0.10, 0.21), p < .001; IL-6, d = 0.25 (95% CI = 0.18, 0.31), p < .001; IL-1, d = 0.35 (95% CI = 0.03, 0.67), p = .03; IL-1ra, d = 0.25 (95% CI = 0.04, 0.46), p = .02. Associations were strongest in clinically depressed patient samples—but were also significant in community-based samples—and when clinical interviews were used. Studies adjusting for body mass index (BMI) had smaller associations, albeit significant. Relationships were inconsistent with respect to age, medication, and sex. Depression was related to CRP and IL-6 among patients with cardiac disease or cancer.

Conclusions: Depression and CRP, IL-1, and IL-6 are positively associated in clinical and community samples and BMI is implicated as a mediating/moderating factor. Continuity in clinic- and community-based samples suggests there is a dose-response relationship between depression and these inflammatory markers, lending strength to the contention that the cardiac (or cancer) risk conferred by depression is not exclusive to patient populations. Available evidence is consistent with three causal pathways: depression to inflammation, inflammation to depression, and bidirectional relationships.

Key Words: depression • inflammation • C-reactive protein • interleukin-1 • interleukin-6 • meta-analysis

Abbreviations: ANS = autonomic nervous system; BDI = Beck Depression Inventory; BMI = body mass index; CAD = coronary artery disease; CES-D = Center for Epidemiological Studies-Depression Scale; CI = confidence interval; CNS = central nervous system; CRH = corticotrophin-releasing hormone; CRP = C-reactive protein; DSM = Diagnostic and Statistical Manual of Mental Disorders; HPA = hypothalamic-pituitary-adrenal; IL = interleukin; IL-1ra = interleukin-1 receptor antagonist; LPS = lipopolysaccharide; MI = myocardial infarction; OTC = over-the-counter; PBMC = Peripheral Blood Mononuclear Cells; PHQ-9 = Depression Module of the Patient Health Questionnaire; SE = Standard Error.




This article has been cited by other articles:


Home page
Psychosom. Med.Home page
J. K. Kiecolt-Glaser, L. Christian, H. Preston, C. R. Houts, W. B. Malarkey, C. F. Emery, and R. Glaser
Stress, Inflammation, and Yoga Practice
Psychosom Med, February 1, 2010; 72(2): 113 - 121.
[Abstract] [Full Text] [PDF]


Home page
GutHome page
G. Barbara and V. Stanghellini
Biomarkers in IBS: when will they replace symptoms for diagnosis and management?
Gut, December 1, 2009; 58(12): 1571 - 1575.
[Full Text] [PDF]


Home page
Psychosom. Med.Home page
L. M. Thornton, B. L. Andersen, T. A. Schuler, and W. E. Carson III
A Psychological Intervention Reduces Inflammatory Markers by Alleviating Depressive Symptoms: Secondary Analysis of a Randomized Controlled Trial
Psychosom Med, September 1, 2009; 71(7): 715 - 724.
[Abstract] [Full Text] [PDF]


Home page
JWatch PsychiatryHome page
Reviews of Note
Journal Watch Psychiatry, June 15, 2009; 2009(615): 1 - 1.
[Full Text]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Copyright © 2009 by the American Psychosomatic Society